Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip A S Lowden

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Chemical Communications (Cambridge, England)|April 8, 2004
The first biosynthetic studies of the azinomycins: acetate incorporation into azinomycin BChristophe Corre, Philip A S Lowden
Chemical Communications (Cambridge, England)|November 16, 2004
Biosynthetic studies on the azinomycins: the pathway to the naphthoate fragmentChristophe Corre, Cyrille A S Landreau, Michael Shipman, et al.
Chembiochem : a European Journal of Chemical Biology|June 9, 2004
New rapamycin derivatives by precursor-directed biosynthesisPhilip A S Lowden, Günter A Böhm, Su Metcalfe, et al.
Angewandte Chemie (International Ed. in English)|March 10, 2001
Origin and True Nature of the Starter Unit for the Rapamycin Polyketide Synthase We thank Dr. Bradley S. Moore for help with the deuterium NMR experiments. This work was supported by grants from The Wellcome Trust (to J.S. and P.F.L.) and from the NIH (AI20264 to H.G.F.)Philip A. S. Lowden, Barrie Wilkinson, Günter A. Böhm, et al.
Annals of Neurology|August 2, 2003
Minocycline and doxycycline are not beneficial in a model of Huntington's diseaseDonna L Smith, Benjamin Woodman, Amarbirpal Mahal, et al.
Chemical Communications (Cambridge, England)|December 6, 2006
Detection of a single DNA base-pair mismatch using an anthracene-tagged fluorescent probeNina Moran, Dario M Bassani, Jean-Pierre Desvergne, et al.
Chemical Communications (Cambridge, England)|August 26, 2003
Electrochemical, in vitro and cell culture analysis of integrated redox catalysts: implications for cancer therapyGregory I Giles, Niroshini M Giles, Catriona A Collins, et al.
ACS Chemical Biology|March 5, 2011
A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylaseDavid M Taylor, Uma Balabadra, Zhongmin Xiang, et al.
Neurobiology of Disease|August 23, 2005
Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's diseaseEmma Hockly, Jamie Tse, Amy L Barker, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2003
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's diseaseEmma Hockly, Victoria M Richon, Benjamin Woodman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Chemical Communications (Cambridge, England)|April 8, 2004
The first biosynthetic studies of the azinomycins: acetate incorporation into azinomycin BChristophe Corre, Philip A S Lowden
Chemical Communications (Cambridge, England)|November 16, 2004
Biosynthetic studies on the azinomycins: the pathway to the naphthoate fragmentChristophe Corre, Cyrille A S Landreau, Michael Shipman, et al.
Chembiochem : a European Journal of Chemical Biology|June 9, 2004
New rapamycin derivatives by precursor-directed biosynthesisPhilip A S Lowden, Günter A Böhm, Su Metcalfe, et al.
Angewandte Chemie (International Ed. in English)|March 10, 2001
Origin and True Nature of the Starter Unit for the Rapamycin Polyketide Synthase We thank Dr. Bradley S. Moore for help with the deuterium NMR experiments. This work was supported by grants from The Wellcome Trust (to J.S. and P.F.L.) and from the NIH (AI20264 to H.G.F.)Philip A. S. Lowden, Barrie Wilkinson, Günter A. Böhm, et al.
Annals of Neurology|August 2, 2003
Minocycline and doxycycline are not beneficial in a model of Huntington's diseaseDonna L Smith, Benjamin Woodman, Amarbirpal Mahal, et al.
Chemical Communications (Cambridge, England)|December 6, 2006
Detection of a single DNA base-pair mismatch using an anthracene-tagged fluorescent probeNina Moran, Dario M Bassani, Jean-Pierre Desvergne, et al.
Chemical Communications (Cambridge, England)|August 26, 2003
Electrochemical, in vitro and cell culture analysis of integrated redox catalysts: implications for cancer therapyGregory I Giles, Niroshini M Giles, Catriona A Collins, et al.
ACS Chemical Biology|March 5, 2011
A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylaseDavid M Taylor, Uma Balabadra, Zhongmin Xiang, et al.
Neurobiology of Disease|August 23, 2005
Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's diseaseEmma Hockly, Jamie Tse, Amy L Barker, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2003
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's diseaseEmma Hockly, Victoria M Richon, Benjamin Woodman, et al.
Pageof 1